Clinical Trial Update: The Analgesic Effect of Scalp Nerve Block Using Bupivacaine Liposomes for Postoperative Pain Relief After Craniotomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is assessing whether scalp nerve block with liposomal bupivacaine reduces postoperative pain after craniotomy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Cerebrovascular Disease

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Zhejiang University | Conditions: Brain Tumor Adult, Cerebrovascular Disease | Phase 4 | Status: RECRUITING